Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
5,892.75
-3.50(-0.06%)
Dow Futures
43,139.00
-38.00(-0.09%)
Nasdaq Futures
20,502.00
-17.50(-0.09%)
Russell 2000 Futures
2,251.00
-4.50(-0.20%)
Crude Oil
70.54
-0.02(-0.03%)
Gold
2,736.50
-2.40(-0.09%)

Chemomab Therapeutics Ltd. (CMMB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

1.6300

+0.0600

(+3.82%)

At close: 04:00PM EDT

1.5899

-0.04

(-2.46%)

After hours:

06:17PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	29.06M
Enterprise Value	16.69M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	2.91
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	0.29
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	2.5500
52 Week Low ³	0.4200
50-Day Moving Average ³	1.5551
200-Day Moving Average ³	1.0072

Share Statistics

Avg Vol (3 month) ³	278.48k
Avg Vol (10 day) ³	174.83k
Shares Outstanding ⁵	18.51M
Implied Shares Outstanding ⁶	N/A
Float ⁸	169.53M
% Held by Insiders ¹	11.50%
% Held by Institutions ¹	26.61%
Shares Short (Sep 30, 2024) ⁴	72.49k
Short Ratio (Sep 30, 2024) ⁴	0.25
Short % of Float (Sep 30, 2024) ⁴	0.39%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	0.39%
Shares Short (prior month Aug 30, 2024) ⁴	215.17k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:16
Last Split Date ³	Mar 17, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-46.18%
Return on Equity (ttm)	-93.80%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-15.97M
Net Income Avi to Common (ttm)	-15M
Diluted EPS (ttm)	-1.0600
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	12.73M
Total Cash Per Share (mrq)	0.04
Total Debt (mrq)	360k
Total Debt/Equity (mrq)	3.61
Current Ratio (mrq)	3.12
Book Value Per Share (mrq)	0.69

Cash Flow Statement

Operating Cash Flow (ttm)	-16.13M
Levered Free Cash Flow (ttm)	-11.36M